Article: article from journal or magazin.
Rhumatologie [Rheumatoid arthritis and ankylosing spondylitis-rheumatologic highlights 2009]
Revue Médicale Suisse
In this year rheumatology highlights, we will especially note a new treatment, the tocilizumab, an interleukin-6 targeting therapy, effective and adequately safe for the treatment of rheumatoid arthritis. New classification criteria for axial spondylarthropathy have also been published, criteria that should facilitate earlier diagnosis, a diagnosis that should be pursue like a diagnosis of rheumatoid arthritis even in the absence of an inflammatory biological syndrome.
Antibodies, Monoclonal/therapeutic use, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, Humans, Spondylitis, Ankylosing/classification
Last modification date